tiprankstipranks
Trending News
More News >
GlucoTrack (GCTK)
NASDAQ:GCTK
US Market

GlucoTrack (GCTK) Technical Analysis

Compare
176 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
GlucoTrack’s (GCTK) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting GlucoTrack is a Sell.
GlucoTrack’s (GCTK) 20-Day exponential moving average is 0.14, while GlucoTrack’s (GCTK) share price is $0.14, making it a Sell.
GlucoTrack’s (GCTK) 50-Day exponential moving average is 0.41, while GlucoTrack’s (GCTK) share price is $0.14, making it a Sell.

GlucoTrack (GCTK) Pivot Points

Jun 07, 2025, 07:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.13
0.13
0.14
0.14
0.15
0.15
0.16
Fibonacci
0.13
0.13
0.14
0.14
0.14
0.15
0.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlucoTrack (GCTK) Moving Averages

Jun 07, 2025, 07:30 PM
Period
Simple
Exponential
MA5
0.14Buy
0.14Buy
MA10
0.13Buy
0.14Buy
MA20
0.14Sell
0.14Sell
MA50
0.16Sell
0.41Sell
MA100
0.48Sell
3.02Sell
MA200
14.83Sell
14.33Sell
GlucoTrack’s (GCTK) 10-Day exponential moving average is 0.14, while GlucoTrack’s (GCTK) share price is $0.14, making it a Buy.
GlucoTrack’s (GCTK) 100-Day exponential moving average is 3.02, while GlucoTrack’s (GCTK) share price is $0.14, making it a Sell.
GlucoTrack’s (GCTK) stock price is $0.14 and GlucoTrack’s (GCTK) 50-day simple moving average is 0.16, creating a Sell signal.
GlucoTrack’s (GCTK) stock price is $0.14 and GlucoTrack’s (GCTK) 100-day simple moving average is 0.48, creating a Sell signal.
GlucoTrack’s (GCTK) stock price is $0.14 and GlucoTrack’s (GCTK) 200-day simple moving average is 14.83, creating a Sell signal.

GlucoTrack (GCTK) Technical Indicators

Jun 07, 2025, 07:30 PM
Name
Value
Implied Action
RSI (14)
39.56
Neutral
STOCH (9,6)
36.96
Neutral
STOCHRSI (14)
36.96
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
9.75
Buy
Williams %R
-63.04
Buy
CCI (14)
1.57
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
39.37
Neutral
ROC
-6.67
Sell
GlucoTrack’s (GCTK) Relative Strength Index (RSI) is 39.56, creating a Neutral signal.
GlucoTrack’s (GCTK) Trend Strength Indicator (ADX) is 9.75, creating a Buy signal.
GlucoTrack’s (GCTK) Commodity Channel Index (CCI) is 1.57, creating a Neutral signal.
GlucoTrack’s (GCTK) Price Rate of Change (ROC) is -6.67, creating a Sell signal.

FAQ

Is GCTK a Buy, Hold, or Sell?
Based on GCTK’s technical indicators, GCTK is a Sell.
    What is GCTK’s RSI (14)?
    GCTK’s RSI (14) is 39.56, which suggests GCTK is a Neutral.
      What is GCTK’s MACD?
      GCTK’s MACD is -0.01, which suggests GCTK is a Sell.
        What is GCTK’s 5-day moving average?
        GCTK’s 5-day moving average is 0.14, which suggests GCTK is a Buy.
          What is GCTK’s 20-day moving average?
          GCTK 20-day moving average is 0.14, which suggests GCTK is a Sell.
            What is GCTK’s 50-day moving average?
            GCTK’s 50-day moving average is 0.16, which suggests GCTK is a Sell.
              What is GCTK’s 200-day moving average?
              GCTK’s 200-day moving average is 14.83, which suggests GCTK is a Sell.
                What is GCTK’s Williams % R (14)?
                GCTK’s Williams % R (14) is -63.04, which suggests GCTK is a Buy.
                  What is GCTK’s CCI (14)?
                  GCTK’s CCI (14) is 1.57, which suggests GCTK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis